THE PREPARATION AND SAFETY OF HEPATITIS-B VACCINE

被引:36
作者
HILLEMAN, MR
MCALEER, WJ
BUYNAK, EB
MCLEAN, AA
机构
关键词
D O I
10.1016/S0163-4453(83)96465-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:3 / +
页数:1
相关论文
共 21 条
[11]   PURIFIED AND INACTIVATED HUMAN HEPATITIS-B VACCINE - PROGRESS REPORT [J].
HILLEMAN, MR ;
BUYNAK, EB ;
ROEHM, RR ;
TYTELL, AA ;
BERTLAND, AU ;
LAMPSON, GP .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1975, 270 (02) :401-404
[12]  
HILLEMAN MR, 1982, VIRAL HEPATITIS, P385
[13]  
HILLEMAN MR, 1978, NEW TRENDS DEV VACCI, P155
[14]  
HILLEMAN MR, 1979, VIRUS LIVER, P389
[15]  
HILLEMAN MR, 1981, PERSPECT VIROL, V11, P219
[16]  
Hilleman MR, 1981, P EUROPEAN S HEPATIT, P120
[17]  
IMAI M, 1979, GASTROENTEROLOGY, V76, P242
[18]   VIRAL HEPATITIS, TYPE-B (MS-2 STRAIN) - ACTIVE IMMUNIZATION [J].
KRUGMAN, S ;
GILES, JP ;
HAMMOND, J .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 217 (01) :41-+
[19]   A CONTROLLED CLINICAL-TRIAL OF THE EFFICACY OF THE HEPATITIS-B VACCINE (HEPTAVAX-B) - A FINAL REPORT [J].
SZMUNESS, W ;
STEVENS, CE ;
ZANG, EA ;
HARLEY, EJ ;
KELLNER, A .
HEPATOLOGY, 1981, 1 (05) :377-385
[20]   INACTIVATION OF HEPATITIS-B VIRUS BY 3 METHODS - TREATMENT WITH PEPSIN, UREA, OR FORMALIN [J].
TABOR, E ;
BUYNAK, E ;
SMALLWOOD, LA ;
SNOY, P ;
HILLEMAN, M ;
GERETY, RJ .
JOURNAL OF MEDICAL VIROLOGY, 1983, 11 (01) :1-9